Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometry

References

• Berkowitz SA, Engen JR, Mazzeo JR, Jones GB. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars. Nat Rev Drug Discov. 2012;11:527–540. doi:10.1038/nrd3746.
   PubMed Web of Science ®Google Scholar
• Liu H, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. Heterogeneity of monoclonal antibodies. J Pharm Sci. 2008;97:2426–2447. doi:10.1002/jps.21180.
   PubMed Web of Science ®Google Scholar
• Torkashvand F, Vaziri B. Main quality attributes of monoclonal antibodies and effect of cell culture components. Iran Biomed J. 2017;21:131–141.
   PubMedGoogle Scholar
• Hintersteiner B, Lingg N, Zhang P, Woen S, Hoi KM, Stranner S, Wiederkum S, Mutschlechner O, Schuster M, Loibner H, et al. Charge heterogeneity: basic antibody charge variants with increased binding to Fc receptors. mAbs. 2016;8:1548–1560. doi:10.1080/19420862.2016.1225642.
   PubMed Web of Science ®Google Scholar
• Khawli LA, Goswami S, Hutchinson R, Kwong ZW, Yang J, Wang X, Yao Z, Sreedhara A, Cano T, Tesar DB, et al. Charge variants in IgG1: isolation, characterization, in vitro binding properties and pharmacokinetics in rats. mAbs. 2010;2:613–624. doi:10.4161/mabs.2.6.13333.
   PubMed Web of Science ®Google Scholar
• Lingg N, Berndtsson M, Hintersteiner B, Schuster M, Bardor M, Jungbauer A. Highly linear pH gradients for analyzing monoclonal antibody charge heterogeneity in the alkaline range: validation of the method parameters. J Chrom A. 2014;1373:124–130. doi:10.1016/j.chroma.2014.11.021.
   PubMed Web of Science ®Google Scholar
• Du Y, Walsh A, Ehrick R, Xu W, May K, Liu H. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. mAbs. 2012;4:578–585. doi:10.4161/mabs.21328.
   PubMed Web of Science ®Google Scholar
• Sluyterman LAA, Elgersma O. Chromatofocusing - isoelectric-focusing on ion-exchange columns .1. General principles. J Chrom. 1978;150:17–30. doi:10.1016/S0021-9673(01)92092-8.
   Web of Science ®Google Scholar
• Sluyterman LAA, Wijdenes J. Chromatofocusing - isoelectric-focusing on ion-exchange columns .2. Experimental-verification. J Chrom. 1978;150:31–44. doi:10.1016/S0021-9673(01)92093-X.
   Web of Science ®Google Scholar
• Sluyterman LAA, Wijdenes J. Chromatofocusing .3. The properties of a deae-agarose anion-exchanger and its suitability for protein separations. J Chrom. 1981;206:429–440. doi:10.1016/S0021-9673(00)88912-8.
   Web of Science ®Google Scholar
• Fekete S, Beck A, Veuthey JL, Guillarme D. Ion-exchange chromatography for the characterization of biopharmaceuticals. J Pharm Biomed Anal. 2015;113:43–55. doi:10.1016/j.jpba.2015.02.037.
   PubMed Web of Science ®Google Scholar
• Fekete S, Beck A, Fekete J, Guillarme D. Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part I: salt gradient approach. J Pharm Biomed Anal. 2015;102:33–44. doi:10.1016/j.jpba.2014.08.035.
   PubMed Web of Science ®Google Scholar
• Fekete S, Beck A, Fekete J, Guillarme D. Method development for the separation of monoclonal antibody charge variants in cation exchange chromatography, Part II: pH gradient approach. J Pharm Biomed Anal. 2015;102:282–289. doi:10.1016/j.jpba.2014.09.032.
   PubMed Web of Science ®Google Scholar
• Patel BA, Pinto NDS, Gospodarek A, Kilgore B, Goswami K, Napoli WN, Desai J, Heo JH, Panzera D, Pollard D, et al. On-line ion exchange liquid chromatography as a process analytical technology for monoclonal antibody characterization in continuous bioprocessing. Anal Chem. 2017;89:11357–11365. doi:10.1021/acs.analchem.7b02228.
   PubMed Web of Science ®Google Scholar
• Griaud F, Denefeld B, Lang M, Hensinger H, Haberl P, Berg M. Unbiased in-depth characterization of CEX fractions from a stressed monoclonal antibody by mass spectrometry. mAbs. 2017;9:820–830. doi:10.1080/19420862.2017.1313367.
   PubMed Web of Science ®Google Scholar
• Stoll DR, Hannes DC, Danforth J, Wagner E, Guillarme D, Fekete S, Beck A. Direct identification of rituximab main isoforms and subunit analysis by online selective comprehensive two-dimensional liquid chromatography-mass spectrometry. Anal Chem. 2015;87:8307–8315. doi:10.1021/acs.analchem.5b01578.
   PubMed Web of Science ®Google Scholar
• Muneeruddin K, Bobst CE, Frenkel R, Houde D, Turyan I, Sosic Z, Kaltashov IA. Characterization of a PEGylated protein therapeutic by ion exchange chromatography with on-line detection by native ESI MS and MS/MS. Analyst. 2017;142:336–344. doi:10.1039/c6an02041k.
   PubMed Web of Science ®Google Scholar
• Muneeruddin K, Nazzaro M, Kaltashov IA. Characterization of intact protein conjugates and biopharmaceuticals using ion-exchange chromatography with online detection by native electrospray ionization mass spectrometry and top-down tandem mass spectrometry. Anal Chem. 2015;87:10138–10145. doi:10.1021/acs.analchem.5b02982.
   PubMed Web of Science ®Google Scholar
• Talebi M, Nordborg A, Gaspar A, Lacher NA, Wang Q, He XZ, Haddad PR, Hilder EF. Charge heterogeneity profiling of monoclonal antibodies using low ionic strength ion-exchange chromatography and well-controlled pH gradients on monolithic columns. J Chrom A. 2013;1317:148–154. doi:10.1016/j.chroma.2013.08.061.
   PubMed Web of Science ®Google Scholar
• Fussl F, Cook K, Scheffler K, Farrell A, Mittermayr S, Bones J. Charge variant analysis of monoclonal antibodies using direct coupled ph gradient cation exchange chromatography to high resolution native mass spectrometry. Anal Chem. 2018. doi:10.1021/acs.analchem.7b05241.
   PubMedGoogle Scholar
• Tebbey PW, Varga A, Naill M, Clewell J, Venema J. Consistency of quality attributes for the glycosylated monoclonal antibody Humira (R) (adalimumab). mAbs. 2015;7:805–811. doi:10.1080/19420862.2015.1073429.
   PubMed Web of Science ®Google Scholar
• Liu J, Eris T, Li C, Cao S, Kuhns S. Assessing analytical similarity of proposed amgen biosimilar ABP 501 to adalimumab. BioDrugs. 2016;30:321–338. doi:10.1007/s40259-016-0184-3.
   PubMed Web of Science ®Google Scholar
• Goyon A, Excoffier M, Janin-Bussat MC, Bobaly B, Fekete S, Guillarme D, Beck A. Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1065-1066:119–128. doi:10.1016/j.jchromb.2017.09.033.
   PubMed Web of Science ®Google Scholar
• Makarov A, Denisov E. Dynamics of ions of intact proteins in the Orbitrap mass analyzer. J Am Soc Mass Spectrom. 2009;20:1486–1495. doi:10.1016/j.jasms.2009.03.024.
   PubMed Web of Science ®Google Scholar
• Chu GC, Chelius D, Xiao G, Khor HK, Coulibaly S, Bondarenko PV. Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures. Pharm Res. 2007;24:1145–1156. doi:10.1007/s11095-007-9241-4.
   PubMed Web of Science ®Google Scholar
• Ponniah G, Nowak C, Neill A, Liu H. Characterization of charge variants of a monoclonal antibody using weak anion exchange chromatography at subunit levels. Anal Biochem. 2017;520:49–57. doi:10.1016/j.ab.2016.12.017.
   PubMed Web of Science ®Google Scholar
• Harris RJ, Kabakoff B, Macchi FD, Shen FJ, Kwong M, Andya JD, Shire SJ, Bjork N, Totpal K, Chen AB. Identification of multiple sources of charge heterogeneity in a recombinant antibody. J Chromatogr B Biomed Sci Appl. 2001;752:233–245. doi:10.1016/S0378-4347(00)00548-X.
   PubMed Web of Science ®Google Scholar
• Vlasak J, Ionescu R. Fragmentation of monoclonal antibodies. mAbs. 2011;3:253–263.
   PubMed Web of Science ®Google Scholar
• Kaschak T, Boyd D, Lu F, Derfus G, Kluck B, Nogal B, Emery C, Summers C, Zheng K, Bayer R, et al. Characterization of the basic charge variants of a human IgG1 Effect of copper concentration in cell culture media. mAbs. 2011;3:577–583. doi:10.4161/mabs.3.6.17959.
   PubMed Web of Science ®Google Scholar
• Ponniah G, Kita A, Nowak C, Neill A, Kori Y, Rajendran S, Liu H. Characterization of the acidic species of a monoclonal antibody using weak cation exchange chromatography and LC-MS. Anal Chem. 2015;87:9084–9092. doi:10.1021/acs.analchem.5b02385.
   PubMed Web of Science ®Google Scholar
• Neill A, Nowak C, Patel R, Ponniah G, Gonzalez N, Miano D, Liu H. Characterization of recombinant monoclonal antibody charge variants using OFFGEL fractionation, weak anion exchange chromatography, and mass spectrometry. Anal Chem. 2015;87:6204–6211. doi:10.1021/acs.analchem.5b01452.
   PubMed Web of Science ®Google Scholar
• Gandhi S, Ren D, Xiao G, Bondarenko P, Sloey C, Ricci MS, Krishnan S. Elucidation of degradants in acidic peak of cation exchange chromatography in an IgG1 monoclonal antibody formed on long-term storage in a liquid formulation. Pharm Res. 2012;29:209–224. doi:10.1007/s11095-011-0536-0.
   PubMed Web of Science ®Google Scholar
• Banks DD, Hambly DM, Scavezze JL, Siska CC, Stackhouse NL, Gadgil HS. The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studies. J Pharm Sci. 2009;98:4501–4510. doi:10.1002/jps.21749.
   PubMed Web of Science ®Google Scholar
• Fischer S, Hoernschemeyer J, Mahler HC. Glycation during storage and administration of monoclonal antibody formulations. Eur J Pharm Biopharm. 2008;70:42–50. doi:10.1016/j.ejpb.2008.04.021.
   PubMed Web of Science ®Google Scholar
• Gadgil HS, Bondarenko PV, Pipes G, Rehder D, McAuley A, Perico N, Dillon T, Ricci M, Treuheit M. The LC/MS analysis of glycation of IgG molecules in sucrose containing formulations. J Pharm Sci. 2007;96:2607–2621. doi:10.1002/jps.20966.
   PubMed Web of Science ®Google Scholar
• Quan C, Alcala E, Petkovska I, Matthews D, Canova-Davis E, Taticek R, Ma S. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior. Anal Biochem. 2008;373:179–191. doi:10.1016/j.ab.2007.09.027.
   PubMed Web of Science ®Google Scholar
• Gao SX, Zhang Y, Stansberry-Perkins K, Buko A, Bai S, Nguyen V, Brader ML. Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity. Biotechnol Bioeng. 2011;108:977–982. doi:10.1002/bit.22982.
   PubMed Web of Science ®Google Scholar
• Robert F, Bierau H, Rossi M, Agugiaro D, Soranzo T, Broly H, Mitchell-Logean C. Degradation of an Fc-fusion recombinant protein by host cell proteases: identification of a CHO cathepsin D protease. Biotechnol Bioeng. 2009;104:1132–1141. doi:10.1002/bit.22494.
   PubMed Web of Science ®Google Scholar
• Wang W, Ignatius AA, Thakkar SV. Impact of residual impurities and contaminants on protein stability. J Pharm Sci. 2014;103:1315–1330. doi:10.1002/jps.23931.
   PubMed Web of Science ®Google Scholar
• Bee JS, Tie L, Johnson D, Dimitrova MN, Jusino KC, Afdahl CD. Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product. Biotechnol Prog. 2015;31:1360–1369. doi:10.1002/btpr.2150.
   PubMed Web of Science ®Google Scholar
• Cohen SL, Price C, Vlasak J. Beta-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage. J Am Chem Soc. 2007;129:6976–6977. doi:10.1021/ja0705994.
   PubMed Web of Science ®Google Scholar
• Cordoba AJ, Shyong BJ, Breen D, Harris RJ. Non-enzymatic hinge region fragmentation of antibodies in solution. J Chrom B. 2005;818:115–121. doi:10.1016/j.jchromb.2004.12.033.
   PubMed Web of Science ®Google Scholar
• Gaza-Bulseco G, Liu H. Fragmentation of a recombinant monoclonal antibody at various pH. Pharm Res. 2008;25:1881–1890. doi:10.1007/s11095-008-9606-3.
   PubMed Web of Science ®Google Scholar
• Xiang T, Lundell E, Sun Z, Liu H. Structural effect of a recombinant monoclonal antibody on hinge region peptide bond hydrolysis. J Chrom B. 2007;858:254–262. doi:10.1016/j.jchromb.2007.08.043.
   PubMed Web of Science ®Google Scholar
• Rawlings ND, Barrett AJ, Bateman A. MEROPS: the peptidase database. Nucleic Acids Res. 2010;38:D227–33. doi:10.1093/nar/gkp971.
   PubMed Web of Science ®Google Scholar
• Rawlings ND. Peptidase specificity from the substrate cleavage collection in the MEROPS database and a tool to measure cleavage site conservation. Biochimie. 2016;122:5–30. doi:10.1016/j.biochi.2015.10.003.
   PubMed Web of Science ®Google Scholar
• Berasain P, Carmona C, Frangione B, Dalton JP, Goni F. Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced. Exp Parasitol. 2000;94:99–110. doi:10.1006/expr.1999.4479.
   PubMed Web of Science ®Google Scholar
• Diepold K, Bomans K, Wiedmann M, Zimmermann B, Petzold A, Schlothauer T, Mueller R, Moritz B, Stracke JO, Mølhøj M, et al. Simultaneous assessment of asp isomerization and asn deamidation in recombinant antibodies by LC-MS following incubation at elevated temperatures. PloS one. 2012;7:ARTN e30295. doi:10.1371/journal.pone.0030295.
   Web of Science ®Google Scholar
• Haberger M, Bomans K, Diepold K, Hook M, Gassner J, Schlothauer T, Zwick A, Spick C, Kepert JF, Hienz B, et al. Assessment of chemical modifications of sites in the CDRs of recombinant antibodies Susceptibility vs. functionality of critical quality attributes. mAbs. 2014;6:327–339. doi:10.4161/mabs.27876.
   PubMed Web of Science ®Google Scholar
• Gstottner C, Klemm D, Haberger M, Bathke A, Wegele H, Bell C, Kopf R. Fast and automated characterization of antibody variants with 4D HPLC/MS. Anal Chem. 2018;90:2119–2125. doi:10.1021/acs.analchem.7b04372.
   PubMed Web of Science ®Google Scholar
• Haberger M, Leiss M, Heidenreich AK, Pester O, Hafenmair G, Hook M, Bonnington L, Wegele H, Haindl M, Reusch D, et al. Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry. mAbs. 2016;8:331–339. doi:10.1080/19420862.2015.1122150.
   PubMed Web of Science ®Google Scholar